Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages
Authors
Soto, Ernesto R.O'Connell, Olivia
Dikengil, Fusun
Peters, Paul J.
Clapham, Paul R.
Ostroff, Gary R.
UMass Chan Affiliations
Program in Molecular MedicineDocument Type
Journal ArticlePublication Date
2016-12-14Keywords
Therapeutics
Metadata
Show full item recordAbstract
Glucan particles (GPs) are hollow, porous 3-5 mum microspheres derived from the cell walls of Baker's yeast (Saccharomyces cerevisiae). The 1,3-beta-glucan outer shell provides for receptor-mediated uptake by phagocytic cells expressing beta-glucan receptors. GPs have been used for macrophage-targeted delivery of a wide range of payloads (DNA, siRNA, protein, small molecules, and nanoparticles) encapsulated inside the hollow GPs or bound to the surface of chemically derivatized GPs. Gallium nanoparticles have been proposed as an inhibitory agent against HIV infection. Here, macrophage targeting of gallium using GPs provides for more efficient delivery of gallium and inhibition of HIV infection in macrophages compared to free gallium nanoparticles.Source
J Drug Deliv. 2016;2016:8520629. Epub 2016 Nov 14. Link to article on publisher's siteDOI
10.1155/2016/8520629Permanent Link to this Item
http://hdl.handle.net/20.500.14038/40211PubMed ID
27965897Related Resources
Link to Article in PubMedRights
Copyright © 2016 Ernesto R. Soto et al.Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.1155/2016/8520629
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2016 Ernesto R. Soto et al.

